XML 121 R103.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT AND GEOGRAPHIC INFORMATION - Segment Reporting Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net $ 1,610,527 $ 1,541,573 $ 1,557,666
Cost of goods sold 728,466 656,838 587,355
Research and development 115,377 104,192 101,193
Selling, general and administrative 716,983 656,641 616,316
Intangible asset amortization 21,290 12,376 13,882
Total costs and expenses 1,582,116 1,430,047 1,318,746
Operating income 28,411 111,526 238,920
Interest income 20,040 17,202 11,917
Interest expense (70,632) (51,377) (49,594)
Gain on sale of business 0 0 644
Other income, net 3,944 3,718 12,007
(Loss) income before income taxes (18,237) 81,069 213,894
Codman Specialty Surgical      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net 1,143,636 1,058,993 1,019,564
Tissue Technologies      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net 466,891 482,580 538,102
Operating Segments | Codman Specialty Surgical      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net 1,143,636 1,058,993 1,019,564
Cost of goods sold 384,422 364,144 345,742
Research and development 30,770 29,984 35,902
Selling, general and administrative 224,370 214,335 220,047
Intangible asset amortization 0 0 0
Total costs and expenses 639,562 608,463 601,691
Operating income 504,074 450,530 417,873
Operating Segments | Tissue Technologies      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net 466,891 482,580 538,102
Cost of goods sold 162,535 164,966 120,937
Research and development 18,140 24,202 28,936
Selling, general and administrative 147,047 159,364 154,427
Intangible asset amortization 0 0 0
Total costs and expenses 327,722 348,532 304,300
Operating income 139,169 134,048 233,802
Corporate and Other      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Total revenue, net 0 0 0
Cost of goods sold 181,509 127,728 120,676
Research and development 66,467 50,006 36,355
Selling, general and administrative 345,566 282,942 241,842
Intangible asset amortization 21,290 12,376 13,882
Total costs and expenses 614,832 473,052 412,755
Operating income $ (614,832) $ (473,052) $ (412,755)